Overview

Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction

Status:
Not yet recruiting

Trial end date:
2021-04-01

Target enrollment:

Participant gender:

Summary

Premature ejaculation (PE) is a common disease in the andrology clinic. Currently, the effectiveness and outcome differences of drug treatment still need to be studied and demonstrated. Premature ejaculation concurrent with erectile dysfunction (ED) is common in outpatient clinics. The preferred treatment plan for these patients still needs to be further studied and explored, and the difference in the efficacy of different treatment regiments remain to be evaluated.

Phase:

Phase 3

Details

Lead Sponsor:

Yan-Ping Huang

Treatments:

Tadalafil